Attorneys for Combe tell HBW Insight that the USPTO appeal board’s decision recognizes the marketplace power of a popular brand like Vagisil. Marke Enterprises' proposed Vagisert trademark for similar product was rejected. 

Former FDA Commissioner Stephen Hahn and former CDC Director Robert Redfield said leaders of their agencies and NIH  should be selected outside the election schedule. White House task force reviewing political interference with agency science.

FDA is conducting lab testing on CBD products with funding in its FY2021 appropriations, says senior agency advisor Sharon Mayl. Some work planned work in the area has been delayed by the agency's response to COVID-19.

FDA is conducting lab testing on CBD products with funding in its FY2021 appropriations, says senior agency advisor Sharon Mayl. Some work planned work in the area has been delayed by the agency's response to COVID-19.

Former FDA commissioner says legislative carve-out for a regulatory pathway for cannabinoids is a better option than a rulemaking, which could take five years and “may not even work.” Cannabinoids market is “well far ahead of where the regulation is,” he says.

Advocates hoped a study suggesting octocrylene in sunscreens may degrade into benzophenone would convince lawmakers to expand ban, but a House committee maintained its commitment to wait on more research.

Attorneys for Combe tell HBW Insight that the USPTO appeal board’s decision recognizes the marketplace power of a popular brand like Vagisil. Marke Enterprises' proposed Vagisert trademark for similar product was rejected. 

Formaldehyde donor DMDM hydantoin may be the ingredient in OGX hair-care products responsible for “hundreds if not thousands” of cases of hair loss and other injuries, plaintiff La Wanda Renee Key suggests in her 5 March class action complaint in California federal court.

“In recent years, health and beauty products containing activated charcoal have become a consumer sensation,” and P&G/Crest has sought to capitalize on demand with falsely advertised charcoal toothpaste offerings, according to plaintiff Belinda Housey’s class action complaint in New York’s Southern District.

The beauty titan will increase its stake in DECIEM to 76% in a deal valuating The Ordinary skin-care owner at $2.2bn. Remaining interests will be acquired after three years, according to the announcement.

Jennifer Montgomery, IFF’s probiotics marketing manager for the Americas, responds to HBW Insight questions about the firm’s plans to deliver probiotics ingredients and technologies following the recent closing of its acquisition of DuPont Nutrition & Biosciences through a merger agreement.

DSM says its nutrition segment, which includes human and animal nutrition and personal care, has a “unique business model combining 'global products' and 'local solutions'” and showed 6% organic sales growth for 2020 and 8% for Q4.

Attorneys for Combe tell HBW Insight that the USPTO appeal board’s decision recognizes the marketplace power of a popular brand like Vagisil. Marke Enterprises' proposed Vagisert trademark for similar product was rejected. 

The Estee Lauder Companies, L’Oreal, J&J, Unilever and subscription beauty box firm BFA Industries are among companies taking action to promote racial equity within their organizations and beyond.

Wellness products accounted for the highest number of launches among health, wellness and beauty products at independent pharmacies in 2020. But the overall number slumped 21.1% due to the pandemic, according to Hamacher Resource Group’s report on a product rating system.

The specialty retailer, entering Target stores in the fall, is aiming for net sales of $7.2bn to $7.3bn in fiscal 2021, compared with $6.15bn in 2020 and $7.4bn in 2019. President Dave Kimbell will be taking the helm in June while CEO Mary Dillon stays on for one year as executive chair of the board.

The New York-based firm reported net sales declines of roughly 10% and 21% for the fiscal 2020 fourth quarter and full year, with COVID-related impacts on color cosmetics weighing heavily on its namesake and Portfolio businesses.

Dermocosmetics was L’Oreal’s biggest growth story in 2020, benefiting from shifting consumer priorities during the COVID crisis and reinvigorated faith in the recommendations of healthcare professionals. Makeup sales tanked, but that could well reverse with the advent of another Roaring Twenties post-pandemic, L’Oreal leadership suggests.

Wellness products accounted for the highest number of launches among health, wellness and beauty products at independent pharmacies in 2020. But the overall number slumped 21.1% due to the pandemic, according to Hamacher Resource Group’s report on a product rating system.

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Mommy’s Bliss will be introducing 16 new products in 2021 for baby and kids with a focus on sleep, immunity support, digestive health, and occasional cough remedies. More product innovation news across the health, beauty and wellness sectors.

Firmenich, Givaudan, IFF and Symrise have decoupled from the Fragrance Creators Association, launching their own trade association to focus on providing technical expertise in North American policy matters. “Any advocacy work has to be based on fact,” says Shawn Blythe, president of the Fragrance Science and Advocacy Council, which intends to partner strategically with FCA and other sister groups.

Formaldehyde donor DMDM hydantoin may be the ingredient in OGX hair-care products responsible for “hundreds if not thousands” of cases of hair loss and other injuries, plaintiff La Wanda Renee Key suggests in her 5 March class action complaint in California federal court.

L’Oreal aims to transform its Research & Innovation by 2030 in line with consumer demand for greener, more natural beauty products. But some ingredients will be much harder to replace than others.

Direct Selling Self-Regulatory Council say after UWell Life didn’t respond to its requests to substantiate ad claims made online for Primocyn brand topicals, the council submitted to its concerns to the FTC.

Pharmavite challenged express and implied claims Goli used online and in social media promoting its product's benefits for weight loss, appetite satiety and craving, heart health, immune, energy, complexion, digestion, bloating, indigestion, heartburn and detoxification.

The National Advertising Division agreed with challenger P&G that Colgate’s evidence for Optic White Renewal Toothpaste was problematic, making its yellow stains claim potentially misleading as to the results consumers can reasonably expect.